Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 62 articles: HTML format

Single Articles

November 2021
1. MA Y, He FJ, Sun Q, Yuan C, et al
   24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
   N Engl J Med. 2021 Nov 13. doi: 10.1056/NEJMoa2109794.
   PubMed     Abstract available
   
   
   
2. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
   Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
   N Engl J Med. 2021;385:1845-1855.
   PubMed     Abstract available
   
   
   October 2021
3. VALGIMIGLI M, Frigoli E, Heg D, Tijssen J, et al
   Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
   N Engl J Med. 2021;385:1643-1655.
   PubMed     Abstract available
   
   
   
4. 
   Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
   N Engl J Med. 2021;385:1632.
   PubMed    
   
   
   August 2021
5. NEAL B, Wu Y, Feng X, Zhang R, et al
   Effect of Salt Substitution on Cardiovascular Events and Death.
   N Engl J Med. 2021 Aug 29. doi: 10.1056/NEJMoa2105675.
   PubMed     Abstract available
   
   
   
6. PITT B, Filippatos G, Agarwal R, Anker SD, et al
   Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
   N Engl J Med. 2021 Aug 28. doi: 10.1056/NEJMoa2110956.
   PubMed     Abstract available
   
   
   
7. JONES WS, Wruck LM, Hernandez AF
   Aspirin Dosing in Cardiovascular Disease. Reply.
   N Engl J Med. 2021;385:765.
   PubMed    
   
   
   
8. JAVOR E, Skelin M, Lucijanic M
   Aspirin Dosing in Cardiovascular Disease.
   N Engl J Med. 2021;385:764-765.
   PubMed    
   
   
   
9. SACRISTAN JA
   Aspirin Dosing in Cardiovascular Disease.
   N Engl J Med. 2021;385:764.
   PubMed    
   
   
   
10. MONACH PA, Branch-Elliman W
    Aspirin Dosing in Cardiovascular Disease.
    N Engl J Med. 2021;385:764.
    PubMed    
    
    
    
11. KALYANI RR
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes. Reply.
    N Engl J Med. 2021;385:671-672.
    PubMed    
    
    
    
12. DONNELLY PE, Winch DE
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    N Engl J Med. 2021;385:670-671.
    PubMed    
    
    
    
13. BOUSSAGEON R, Maynie-Francois C
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    N Engl J Med. 2021;385:670.
    PubMed    
    
    
    
14. INZUCCHI SE, Peixoto AJ, Testani JM
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    N Engl J Med. 2021;385:669-670.
    PubMed    
    
    
    
15. KADIRE SR, Udelson J, Budoff MJ
    Imaging in Coronary Artery Disease Risk Stratification.
    N Engl J Med. 2021;385:655-657.
    PubMed    
    
    
    
16. MATHEW R, Di Santo P, Jung RG, Marbach JA, et al
    Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    N Engl J Med. 2021;385:516-525.
    PubMed     Abstract available
    
    
    July 2021
17. JENKINS DJA, Dehghan M, Yusuf S
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality. Reply.
    N Engl J Med. 2021;385:379-380.
    PubMed    
    
    
    
18. KANTER M, Angadi S, Slavin J
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021;385:378-379.
    PubMed    
    
    
    
19. LEOW MK, Henry CJ
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021;385:378.
    PubMed    
    
    
    
20. JUNI P
    PCI for Nonculprit Lesions in Patients with STEMI - No Role for FFR.
    N Engl J Med. 2021;385:370-371.
    PubMed    
    
    
    
21. VARELA DL, Jones TL
    Perivalvular Abscess Causing Coronary-Artery Compression.
    N Engl J Med. 2021;385:e3.
    PubMed    
    
    
    June 2021
22. GERSTEIN HC, Sattar N, Rosenstock J, Ramasundarahettige C, et al
    Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
    N Engl J Med. 2021 Jun 28. doi: 10.1056/NEJMoa2108269.
    PubMed     Abstract available
    
    
    
23. LAU ES, Scirica B, Schaefer IM, Miller AL, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:2145-2152.
    PubMed    
    
    
    May 2021
24. LOFFI M, Danzi GB
    Isolated Coronary Artery.
    N Engl J Med. 2021;384:e79.
    PubMed    
    
    
    
25. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
    A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
    N Engl J Med. 2021;384:2014-2027.
    PubMed     Abstract available
    
    
    
26. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.
    PubMed    
    
    
    
27. PUYMIRAT E, Cayla G, Simon T, Steg PG, et al
    Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMoa2104650.
    PubMed     Abstract available
    
    
    
28. JONES WS, Mulder H, Wruck LM, Pencina MJ, et al
    Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
    N Engl J Med. 2021 May 15. doi: 10.1056/NEJMoa2102137.
    PubMed     Abstract available
    
    
    
29. RODRIGUEZ F, Harrington RA
    Antithrombotic Therapy after Acute Coronary Syndromes. Reply.
    N Engl J Med. 2021;384:1873-1874.
    PubMed    
    
    
    
30. PARADA BARCIA J, Raposeiras Roubin S, Abu-Assi E
    Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:1873.
    PubMed    
    
    
    
31. BITTL JA
    Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:1872-1873.
    PubMed    
    
    
    
32. KONIG MF, Sathiyakumar V, Phan CM, Schulman SP, et al
    Inside and Out.
    N Engl J Med. 2021;384:1753-1760.
    PubMed    
    
    
    April 2021
33. YUSUF S, Joseph P, Pais P
    Polypill in Persons without Cardiovascular Disease. Reply.
    N Engl J Med. 2021;384:1676-1677.
    PubMed    
    
    
    
34. CAINZOS-ACHIRICA M
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1675-1676.
    PubMed    
    
    
    
35. WALD N, Wald D, Law M
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1675.
    PubMed    
    
    
    
36. MESSERLI FH, Brguljan J, Bangalore S
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1674-1675.
    PubMed    
    
    
    
37. ALAM A, Carey SA, Hall SA
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1674.
    PubMed    
    
    
    
38. GALLIENI M, Paik JM, Fiorina P
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1673-1674.
    PubMed    
    
    
    
39. BHATT DL, Steg PG, Pitt B
    Cardiovascular Outcomes with Sotagliflozin. Reply.
    N Engl J Med. 2021;384:1471-1473.
    PubMed    
    
    
    
40. MARCHAND L, Villar E, Green L
    Cardiovascular Outcomes with Sotagliflozin.
    N Engl J Med. 2021;384:1471.
    PubMed    
    
    
    
41. BAGLIONI P
    Cardiovascular Outcomes with Sotagliflozin.
    N Engl J Med. 2021;384:1470-1471.
    PubMed    
    
    
    
42. KALYANI RR
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    N Engl J Med. 2021;384:1248-1260.
    PubMed    
    
    
    March 2021
43. KIM ESH
    Spontaneous Coronary-Artery Dissection. Reply.
    N Engl J Med. 2021;384:1077-1078.
    PubMed    
    
    
    
44. WANG X, Ge J
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2021;384:1077.
    PubMed    
    
    
    
45. CAMPOCHIARO C, Tomelleri A, Dagna L
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2021;384:1077.
    PubMed    
    
    
    
46. GIBBONS GH, Seidman CE, Topol EJ
    Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
    N Engl J Med. 2021;384:785-788.
    PubMed    
    
    
    February 2021
47. FIOLET ATL, Cornel JH, Thompson PL
    Colchicine in Patients with Chronic Coronary Disease. Reply.
    N Engl J Med. 2021;384:778-779.
    PubMed    
    
    
    
48. D'AMARIO D, Rodolico D, Galli M
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:778.
    PubMed    
    
    
    
49. LUCIJANIC M, Javor E, Skelin M
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:777-778.
    PubMed    
    
    
    
50. FISCHER BG
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:777.
    PubMed    
    
    
    
51. GEBHARD C, Regitz-Zagrosek V
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776-777.
    PubMed    
    
    
    
52. KAISER D, Jackson CD
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776.
    PubMed    
    
    
    
53. JENKINS DJA, Dehghan M, Mente A, Bangdiwala SI, et al
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2007123.
    PubMed     Abstract available
    
    
    
54. RODRIGUEZ F, Harrington RA
    Management of Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:452-460.
    PubMed    
    
    
    January 2021
55. HUFFMAN MD, Patel A
    Polypills - A Central Strategy for Improving Cardiovascular Health.
    N Engl J Med. 2021;384:288-289.
    PubMed    
    
    
    
56. SCOTT NS, Thomas SS, DeFaria Yeh D, Fox AS, et al
    Case 2-2021: A 26-Year-Old Pregnant Woman with Ventricular Tachycardia and Shock.
    N Engl J Med. 2021;384:272-282.
    PubMed    
    
    
    December 2020
57. KIM ESH
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2020;383:2358-2370.
    PubMed    
    
    
    November 2020
58. YUSUF S, Joseph P, Dans A, Gao P, et al
    Polypill with or without Aspirin in Persons without Cardiovascular Disease.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2028220.
    PubMed     Abstract available
    
    
    October 2020
59. LEE TH
    Seizing the Teachable Moment - Lessons from Eisenhower's Heart Attack.
    N Engl J Med. 2020;383:e100.
    PubMed    
    
    
    
60. O'GARA PT, Mack MJ
    Secondary Mitral Regurgitation.
    N Engl J Med. 2020;383:1458-1467.
    PubMed    
    
    
    September 2020
61. CANNON CP, Pratley R, Dagogo-Jack S, Mancuso J, et al
    Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMoa2004967.
    PubMed     Abstract available
    
    
    August 2020
62. KIRCHHOF P, Camm AJ, Goette A, Brandes A, et al
    Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019422.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: